Political Realism Requires Transatlantic Ties
In the interwar years, the U.S. condoned the German military buildup under warped views of equality between Germany and France, and it enforced German reparations while loaning Germany twice the amount of reparations due—defending each policy in a vacuum. After World War II, America made peace with the idea of U.S. involvement in Europe, and it came to understand the necessity of financial investment in Europe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Trailhead Biosystems® Expands Human Cell-Based Product Line with iPSC-Derived A9 Dopaminergic Neurons
BEACHWOOD, Ohio, July 23, 2025 /CNW/ -- Trailhead Biosystems, Inc. ( a biotechnology company pioneering the creation of induced pluripotent stem cell (iPSC)-derived human cells at scale for drug discovery and cell therapy, introduces TrailBio® A9 Dopaminergic Neurons, a powerful new tool available off-the-shelf for studying Parkinson's disease and other neurodegenerative conditions. A9 dopaminergic neurons play a critical role in movement regulation and are disproportionately affected in Parkinson's disease. Historically, researchers have lacked access to viable human models, relying instead on animal studies with limited relevance. With TrailBio® A9 Dopaminergic Neurons, scientists now have a human-specific platform to investigate disease mechanisms, develop therapies and accelerate drug discovery. "TrailBio® A9 Dopaminergic Neurons open new possibilities for Parkinson's research," said Dr. Jan Jensen, Chief Scientific Officer, Chief Technology Officer and founder of Trailhead Biosystems. "These cells enable researchers to study the vulnerabilities of A9 neurons, helping drive progress toward more effective treatments." "For decades, the lack of human A9 neurons has limited our ability to truly understand Parkinson's disease," added Dr. Nooshin Amini, Scientific Director at Trailhead Biosystems. "Now, with TrailBio® A9 Dopaminergic Neurons, researchers can directly study the exact cells that are most affected, offering hope for groundbreaking insights and future therapies." About Trailhead Biosystems Trailhead Biosystems, Inc. is pioneering an informatics-based approach in regenerative medicine and drug discovery. Founded in 2015 as a spinout from the Cleveland Clinic and Case Western Reserve University, Trailhead emerged from the research of CSO/CTO and founder Dr. Jan Jensen. Trailhead creates optimized human cells at scale with its proprietary High-Dimensional Design-of-Experiments (HD-DoE®) platform, integrating advanced mathematical modeling with high-throughput robotic manufacturing. This innovative system allows Trailhead to develop specialized, high-quality iPSC-derived human cells for drug discovery and cell-based therapies. TrailBio® A9 Dopaminergic Neurons represent one of many specialized human cell types emerging from this platform, with additional cell models expected in the near future. Learn more about Trailhead Biosystems, TrailBio® A9 Dopaminergic Neurons and HD-DoE® at For more information, please contact: Tim Mauk, Corporate CommunicationsTrailhead BiosystemsEmail: info@ View original content to download multimedia: SOURCE Trailhead Biosystems Inc View original content to download multimedia:
Yahoo
5 minutes ago
- Yahoo
Voiceflex partners with iPNetix to bolster its UCaaS professional services offering
LONDON, July 23, 2025 /PRNewswire/ -- Leading unified communications provider, Voiceflex, has teamed up with iPNetix – experts in IP solutions and support – to strengthen the delivery of its UCaaS application, Voiceflex Flow. Voiceflex Flow is a full and flexible UCaaS platform delivering all voice and collaboration from one single platform. iPNetix will provide scalable support solutions, ranging from installation-only services to full-service wraparound packages, ensuring Voiceflex Flow partners and their customers receive best-in-class implementation and ongoing assistance. Kevin Boyer, Managing Director at iPNetix said: "Through our channel partner network across various sectors, we deliver unparalleled professional services and support, 24/7, to businesses across the globe. "This strategic partnership with Voiceflex will strengthen the delivery of its UCaaS application by expanding support and installation capabilities through our expert service teams." Paul Taylor, Chief Commercial Officer at Voiceflex, said: "With a growing number of partners actively selling Voiceflex Flow, we were on the lookout for a trusted, channel-only professional services company to partner with. "With iPNetix on board, we're better positioned to address direct customer requests for professional installation and support, while also broadening our reach and enhancing success across the channel." About Voiceflex Voiceflex is a leading provider transitioning from a pure Telco to Techco delivering voice enablement services to the Channel. Our portfolio includes UCaaS, CCaaS, SBCaaS, Ai Meeting, Ai Conversational IVR, WhatsApp Business, and more designed to meet the diverse needs of businesses across various sectors. With a commitment to excellence and customer satisfaction, Voiceflex continues to drive innovation in the telecommunications industry. For more information about Voiceflex or to become a Voiceflex partner, please visit or contact sales@ About iPNetix iPNetix is a UK-based channel-only delivering fully managed, cost-effective, and scalable communications and support solutions. Whether it's full delivery service, design and implementation, project management or its comprehensive support desk, iPNetix services transform how end-user customers connect and collaborate. For more information about iPNetix please visit or contact us on info@ Media contact: Rachel Preston rpreston@ Logo - View original content to download multimedia:
Yahoo
5 minutes ago
- Yahoo
S&P 500 Is Getting More Bitcoin Exposure as Block Joins the Club
Block, Jack Dorsey's Bitcoin-focused payments company, is set to join the S&P 500 on Wednesday, a milestone moment for both the company and and foray further into crypto for the benchmark index. Block (XYZ), which was rebranded from Square in 2021, is the second blockchain company to join the club after cryptocurrency exchange Coinbase Global (COIN) was added to the index in mid-May. That means index fund investors will get a modest bump in exposure to the world's largest cryptocurrency bitcoin (BTCUSD). The company takes the spot vacated by Hess Corp., which was acquired by Chevron (CVX) in a deal that closed July 18. It's the third addition of the month, following The Trade Desk (TTD) and Datadog (DDOG). Since the announcement of Block's inclusion late Friday, the shares have risen 9%. Block's stock has benefited from an index effect, which refers to directional pressure on stocks when a company is added to, or removed from, the S&P 500 and other indexes. The most recent research report on the matter from S&P Dow Jones Indices, which studied the price impact of index additions and deletions from 1995 to June 2021, showed that it isn't always much of a force. The median excess returns—defined here as the difference between a stock's total return and that of the broader index—of stocks added to the index, measured from the announcement date to the effective date, was about 8% from 1995 to 1999. From 2000 to 2010, that number shrank to 3.6%, and was essentially nonexistent from 2011 to 2021. And even if an index effect shows up ahead of the official inclusion or deletion date, according to a McKinsey study, the premium or discount has a tendency to dissipate within a few months. What's new can get old pretty fast. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
